The strongest association was observed for PM₂.₅, the microscopic particles measuring 2.5 micrometres or less in diameter. Because these particles are so small, they can penetrate deep into the lungs and, in some cases, cross into the bloodstream. Their chemical composition varies according to their source, but PM₂.₅ may contain metals, soot, organic compounds and other substances capable of triggering oxidative stress and chronic inflammation. Over time, these biological disturbances can damage DNA, alter immune responses and interfere with normal cellular repair. The new analysis found that every additional 10 micrograms of PM₂.₅ per cubic metre of air was associated with a 16.0 percent increase in the risk of all cancers combined.

The study also identified a J-shaped exposure–response relationship for PM₂.₅. In epidemiology, this pattern indicates that the risk does not rise in a simple straight line across all exposure levels. At lower concentrations, changes in risk may be relatively modest or difficult to distinguish, while at higher concentrations the curve turns upward more sharply. A J-shaped association can reflect biological thresholds, differences in population susceptibility or the effects of particularly intense pollution exposure. It may also emerge when background risks and other environmental factors vary across locations. The researchers used statistical models designed to capture this type of nonlinear pattern rather than assuming that every incremental increase in pollution carries exactly the same effect.

Ozone, commonly known as O₃, showed a different pattern. Unlike the protective ozone layer high in the atmosphere, ground-level ozone is a harmful pollutant formed when nitrogen oxides and volatile organic compounds react in sunlight. It is often more severe during hot, sunny conditions and can travel across administrative boundaries, making it difficult for individual cities to control. Ozone irritates the airways and can promote inflammation throughout the respiratory system. According to the study, each 10 micrograms per cubic metre increase in long-term ozone exposure was associated with a 4.23 percent rise in the risk of all cancers. The relationship was described as near-linear, meaning that the estimated risk increased more steadily as exposure rose.

Nitrogen dioxide, or NO₂, was associated with an 11.7 percent increase in all-cancer risk for every 10 micrograms per cubic metre increase in long-term exposure. The gas is generated primarily by fuel combustion, especially from vehicles, power plants and industrial activity. It can damage airway tissues directly and also contributes to the formation of ozone and secondary particles. Nitrogen dioxide is therefore both a pollutant in its own right and part of a wider atmospheric chemical system. Exposure is frequently highest near busy roads and in densely populated urban areas, where traffic emissions can create sharp differences in air quality from one neighbourhood to another.

When the researchers translated these relative risks into population-level estimates, the scale of the findings became considerably larger. PM₂.₅ exposure was estimated to be associated with approximately 8.82 million incident cancer cases worldwide during the study period. Ozone was linked to about 2.59 million cases, while nitrogen dioxide was associated with approximately 6.67 million cases. These figures represent attributable burdens calculated from population exposure and estimated risk relationships; they do not mean that every individual case can be traced to a single pollutant. Cancer is a multifactorial disease influenced by age, genetics, smoking, alcohol use, infections, diet, occupational hazards and access to medical care. Nevertheless, even a modest increase in risk can produce a substantial number of cases when it affects billions of people.

The researchers used distributed lag non-linear models, a method that can evaluate both delayed effects and nonlinear exposure patterns. Cancer often develops over years or decades, so the consequences of an exposure may not appear immediately after pollution levels rise. Distributed lag models allow investigators to examine how risk may accumulate across time rather than assigning all effects to the moment of exposure. The approach can also account for changing exposure levels, differences between locations and potential variations in the time required for environmental damage to contribute to disease. By combining these models with global cancer and pollution data, the study aimed to estimate not only relative risks but also the number of cases potentially linked to ambient air pollution.

One of the study’s most striking observations was the consistently higher attributable risk and burden among women for most malignancies. The analysis does not establish a single explanation for this difference, and the causes may vary by region and cancer type. Women and men can experience different occupational and household exposures, including pollution from cooking fuels, heating systems and poorly ventilated indoor environments. Biological differences in hormone regulation, immune function, body composition and pollutant metabolism could also influence susceptibility. In addition, patterns of healthcare access, diagnosis and cancer registration may affect the data. The finding highlights the importance of examining air pollution through a sex-specific lens rather than assuming that the same exposure produces identical outcomes in every population.

The results arrive as cities worldwide confront overlapping challenges from traffic emissions, industrial pollution, wildfires and climate-driven heat extremes. Fine particles can travel long distances, while hot weather can intensify ozone formation and increase the frequency of stagnant-air episodes. Reducing fossil-fuel combustion, improving public transport, tightening industrial standards, expanding clean household energy and monitoring pollution at neighbourhood scale could therefore deliver benefits beyond cardiovascular and respiratory health. The authors describe their estimates as an impetus for stronger public-health policies aimed at reducing the global cancer burden. Although the study is observational and its estimates depend on the quality of exposure data, cancer records and statistical assumptions, its vast geographic scope underscores a central message: cleaner air may be one of the most consequential cancer-prevention measures available to governments and communities.

Subject of Research: Global cancer burden associated with long-term exposure to ambient air pollution

Article Title: Global cancer burden associated with long-term exposure to ambient air pollution

Article References: Zhang, G., Li, Y., Li, A. et al. Global cancer burden associated with long-term exposure to ambient air pollution. Nat. Health (2026). https://doi.org/10.1038/s44360-026-00180-4

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s44360-026-00180-4

Keywords: Air pollution, PM₂.₅, ozone, nitrogen dioxide, cancer, public health, environmental epidemiology, global health, attributable burden

Originally conceptualized to identify modifiable risk factors associated with brain health, the McCance Brain Care Score has now emerged as a versatile tool that transcends neurological boundaries. Developed at Mass General Brigham, this 21-point instrument evaluates a comprehensive array of physical, lifestyle, and socio-emotional parameters that collectively dictate brain wellness. Through rigorous statistical analysis of expansive longitudinal data drawn from the UK Biobank — encompassing over 400,000 participants aged 40 to 69 years — researchers have elucidated previously unrecognized correlations that link brain care directly with systemic health outcomes.

The McCance BCS encapsulates risk components that are often seen individually in clinical practice but rarely integrated into a single, practical metric. Its strength lies in quantifying modifiable behaviors and physiological markers such as nutrition quality, amount and intensity of physical activity, tobacco and alcohol consumption, blood pressure, cholesterol levels, blood glucose regulation, and psycho-social factors including perceived stress and social isolation. This multifaceted approach reflects cutting-edge understanding of the complex interplay between mental and physical health, underscoring the brain’s role as a central orchestrator of overall well-being.

Key findings from this analysis are striking in scale: every five-point increment increase in the Brain Care Score correlates with a 43% reduction in cardiovascular disease incidence, encompassing conditions like ischemic heart disease, heart failure, and stroke, over a median follow-up period exceeding a decade. Additionally, a comparable five-point score elevation corresponds to a 31% lowered risk for lung, colorectal, and breast cancers — cancers that together represent a significant global burden in morbidity and mortality. These associations suggest brain health may serve not only as a vital indicator of neurological integrity but also as a sentinel marker reflecting broader systemic resilience.

This investigation leverages the depth and breadth of the UK Biobank, whose extensive dataset enables integrated analyses that control for numerous confounding variables, lending robustness to observed associations. The large sample size, diversity in demographic and clinical characteristics, and longitudinal follow-up strengthen the external validity and potential translational relevance of these findings. Yet study authors caution that while these associations are statistically significant and biologically plausible, they do not establish direct causation, underscoring the necessity for further mechanistic studies and interventional trials.

Critically, many individual factors embedded within the BCS have documented causal impacts on disease risk. For example, smoking cessation, blood pressure management, and regular physical exercise are well-established pillars of cardiovascular and oncological risk reduction, supported by rigorous clinical evidence. The innovation here is the encapsulation of these elements into a singular composite score that simplifies risk communication and empowers patients and clinicians alike to systematically address modifiable factors that influence multiple health domains simultaneously.

The psychobiological underpinnings of these linkages may reflect shared pathophysiological mechanisms including chronic inflammation, oxidative stress, immune dysregulation, and metabolic disturbances. Additionally, psychosocial determinants such as chronic stress and social isolation are increasingly recognized as potent contributors to systemic disease processes, further justifying the inclusion of socio-emotional variables within the BCS framework. This holistic perspective embodies a paradigm shift toward integrated brain-body as opposed to siloed organ-specific medicine.

Lead investigator Dr. Sanjula Singh, affiliated with the McCance Center for Brain Health at Massachusetts General Hospital, conceptualizes these findings as reinforcing the interconnectedness of brain health with cardiovascular and oncologic outcomes. She articulates a vision in which optimizing brain care equates to systemic health preservation, and suggests the BCS could become a practical, time-efficient screening and counseling tool in primary care settings. This could substantially alleviate the burden on clinicians facing increasingly complex chronic disease portfolios within constrained consultation times.

Co-author Dr. Jasper Senff emphasizes patient empowerment as a core objective, noting that the brain care score translates scientific complexity into actionable insights. Encouraging patients to achieve incremental improvements in their Brain Care Score may facilitate meaningful behavioral changes that cascade into reductions in cardiovascular and cancer risk. This aligns with contemporary preventive medicine strategies prioritizing lifestyle modification over pharmacotherapy whenever feasible.

The study acknowledges certain limitations intrinsic to its design. The exclusive focus on middle-aged and older adults enrolled in the UK Biobank may limit applicability to younger populations or diverse ethnic groups not well represented in this cohort. Furthermore, the BCS is intentionally broad and not intended as a diagnostic or prognostic model for any specific disease. Instead, it functions as an accessible framework to guide lifestyle-oriented interventions targeting brain health variables with systemic implications.

Funding for this transformative investigation was provided by the National Institutes of Health and the American Heart Association, organizations renowned for supporting high-impact research that bridges neuroscience, cardiology, and oncology. Notably, the funders remained uninvolved in study design, data analysis, or dissemination, ensuring scientific independence. Disclosures reveal no conflicts of interest among the research team, lending credibility to their findings.

In conclusion, this landmark study positions the McCance Brain Care Score as a pioneering multidimensional tool that encapsulates the intrinsic links between brain health and major chronic diseases. The implications for future research, clinical practice, and public health policy are profound. Integrating brain care metrics into routine medical assessments may catalyze a more holistic approach to disease prevention, fostering a new era of precision wellness. As efforts continue to unravel the shared etiological threads among neurological, cardiovascular, and oncological conditions, tools like the BCS herald a promising convergence of brain health with systemic longevity.

Subject of Research: People

Article Title: The Brain Care Score and the Association with Cardiovascular Disease and Cancer

News Publication Date: 4-Jun-2025

Web References:

• https://academic.oup.com/fampra/article-abstract/42/4/cmaf034/8156506?redirectedFrom=fulltext
• https://www.massgeneralbrigham.org/
• https://www.thelancet.com/journals/laneur/article/PIIS1474-4422(22)00397-0/fulltext

References: Senff JR et al. “The Brain Care Score and the Association with Cardiovascular Disease and Cancer,” Family Practice, DOI: 10.1093/fampra/cmaf034

Keywords: Cardiovascular disease, Cancer, Preventive medicine, Physical exercise, Human health